Omnicell Inc (FRA:OC9)
€ 41.8 -0.8 (-1.88%) Market Cap: 1.96 Bil Enterprise Value: 1.99 Bil PE Ratio: 0 PB Ratio: 1.66 GF Score: 74/100

Omnicell Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 07:00PM GMT
Release Date Price: €97.5 (+1.56%)
Edwin Barkhordarian
JP Morgan Chase & Co. - Investment Banking Associate of Healthcare

Good afternoon. My name is Edwin Barkhordarian, and I'm a member of the JPMorgan Health Care Investment Banking team. Thank you all for joining today, and it is my pleasure to introduce Randall Lipps, CEO of Omnicell.

As a reminder, you may submit questions through the ask-a-question feature listed under the presentation. Thank you.

Randall A. Lipps
Omnicell, Inc. - Founder, Executive Chairman, President & CEO

Well, thanks for joining us today. It's really nice to have you. And as we flip through the slides, I'll let you know which one we're on.

So if you will go to the disclaimers page, please. This is our normal standard disclosures page. Thank you.

If you would advance to the next slide entitled vision, fundamentally, our vision is out to change one of the largest and most significant areas in health care. 27 years ago, when I started this business, we were focused on supply chain and medication management and working through areas

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot